Annelise Brossel

Annelise Brossel is Director, Regulatory Affairs & Quality Assurance at Vivet Therapeutics.

Journal
Case studies: The impact of the In Vitro Diagnostic Regulation on ATMP clinical trials and drug development plans
2025-05-02T13:41:00
This article looks at the impact of the In Vitro Diagnostic Medical Devices Regulation (EU) 2017/746 (IVDR) and uses case studies to help improve ATMP development.